Literature DB >> 27126918

Different effects of arginine vasopressin on high-mobility group box 1 expression in astrocytes isolated from stroke-prone spontaneously hypertensive rats and congenic SHRpch1_18 rats.

Kazuo Yamagata1, Natumi Sone1, Sari Suguyama1, Toru Nabika2.   

Abstract

Stroke-prone spontaneously hypertensive rats (SHRSP/Izm) develop severe hypertension and astrocytic oedema following ischaemic stimulation. During ischaemic stress high-mobility group box 1 (Hmgb1) expression in astrocytes is induced, and subsequently potentiates deterioration of the brain due to ischaemic injury, which manifests as both cerebral inflammation and astrocytic oedema. Arginine vasopressin (AVP) induces brain injury and increases astrocytic swelling. After stroke, Hmgb1 and peroxiredoxin (Prx) are released at different times and activate macrophages in the brain via Toll-like receptors (Tlr2s). The purpose of this study was to examine whether AVP and/or hypoxia and reoxygenation (H/R) contribute to Hmgb1 regulation following ischaemic stroke. Thus, Hmgb1, Prx2 and Tlr2 expression levels in astrocytes isolated from Wistar Kyoto rats (WKY/Izm), spontaneously hypertensive rats (SHR/Izm), SHRSP/Izm and congenic rat strain SHRpch1_18 treated with AVP and/or H/R were compared. Gene and protein expression levels were determined by reverse transcriptase-polymerase chain reaction (RT-PCR) and real-time quantitative PCR, and Western blot. mRNA expression of Hmgb1, Prx2 and Tlr2 induced by AVP was dose-dependent, and Hmgb1 and Prx2 expression was higher in SHR/Izm, SHRSP/Izm and SHRch1_18 than in WKY/Izm. Tlr2 expression with AVP was reduced in SHR/Izm compared to WKY/Izm. In SHRpch1_18, Hmgb1 expression increased after AVP plus H/R. AVP-modulated expression of Hmgb1 protein was reduced by the addition of the antioxidant N-acetylcysteine (NAC). These results suggest that oxidative stress by AVP enhanced expression of Hmgb1, Prx2 and Tlr2 in astrocytes. We hypothesize that regulation of Hmgb1 by AVP during H/R might be related to induction of inflammation and stroke in SHRSP/Izm and SHRpch1_18 rats.
© 2016 The Authors. International Journal of Experimental Pathology © 2016 International Journal of Experimental Pathology.

Entities:  

Keywords:  HMGB1; SHRSP; astrocytes

Mesh:

Substances:

Year:  2016        PMID: 27126918      PMCID: PMC4926054          DOI: 10.1111/iep.12172

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  38 in total

1.  Importance of genetic factors in stroke: an evidence obtained by selective breeding of stroke-prone and -resistant SHR.

Authors:  Y Yamori
Journal:  Jpn Circ J       Date:  1974-12

2.  Arginine vasopressin regulated ASCT1 expression in astrocytes from stroke-prone spontaneously hypertensive rats and congenic SHRpch1_18 rats.

Authors:  K Yamagata; M Yamamoto; K Kawakami; H Ohara; T Nabika
Journal:  Neuroscience       Date:  2014-03-06       Impact factor: 3.590

3.  HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain.

Authors:  Jung-Bin Kim; Joon Sig Choi; Young-Mi Yu; Kihoon Nam; Chun-Shu Piao; Seung-Woo Kim; Min-Hyung Lee; Pyung-Lim Han; Jong-Sang Park; Ja-Kyeong Lee
Journal:  J Neurosci       Date:  2006-06-14       Impact factor: 6.167

4.  Differential regulation of glial cell line-derived neurotrophic factor (GDNF) mRNA expression during hypoxia and reoxygenation in astrocytes isolated from stroke-prone spontaneously hypertensive rats.

Authors:  Kazuo Yamagata; Motoki Tagami; Katsumi Ikeda; Shigehisa Tsumagari; Yukio Yamori; Yasuo Nara
Journal:  Glia       Date:  2002-01       Impact factor: 7.452

5.  Role of ERK map kinase and CRM1 in IL-1beta-stimulated release of HMGB1 from cortical astrocytes.

Authors:  Kazuhide Hayakawa; Ken Arai; Eng H Lo
Journal:  Glia       Date:  2010-06       Impact factor: 7.452

Review 6.  Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke.

Authors:  Kazuhide Hayakawa; Jianhua Qiu; Eng H Lo
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

Review 7.  Neuronal vulnerability of stroke-prone spontaneously hypertensive rats to ischemia and its prevention with antioxidants such as vitamin E.

Authors:  K Yamagata; M Tagami; Y Yamori
Journal:  Neuroscience       Date:  2010-07-13       Impact factor: 3.590

8.  Severe stroke induces long-lasting alterations of high-mobility group box 1.

Authors:  Juliane Schulze; Dannielle Zierath; Patricia Tanzi; Kevin Cain; Dean Shibata; Alexander Dressel; Kyra Becker
Journal:  Stroke       Date:  2012-11-29       Impact factor: 7.914

9.  Effects of L-serine on neurons in vitro.

Authors:  R Savoca; U Ziegler; P Sonderegger
Journal:  J Neurosci Methods       Date:  1995 Sep-Oct       Impact factor: 2.390

10.  TLR2 has a detrimental role in mouse transient focal cerebral ischemia.

Authors:  Gina Ziegler; Denise Harhausen; Claudia Schepers; Olaf Hoffmann; Christina Röhr; Vincent Prinz; Janett König; Hans Lehrach; Wilfried Nietfeld; George Trendelenburg
Journal:  Biochem Biophys Res Commun       Date:  2007-05-30       Impact factor: 3.575

View more
  3 in total

1.  Chlorogenic acid regulates apoptosis and stem cell marker-related gene expression in A549 human lung cancer cells.

Authors:  Kazuo Yamagata; Yuri Izawa; Daiki Onodera; Motoki Tagami
Journal:  Mol Cell Biochem       Date:  2017-09-05       Impact factor: 3.396

2.  Arginine vasopressin altered the expression of monocarboxylate transporters in cultured astrocytes isolated from stroke-prone spontaneously hypertensive rats and congenic SHRpch1_18 rats.

Authors:  Kazuo Yamagata; Natsumi Takahashi; Nozomi Akita; Toru Nabika
Journal:  J Neuroinflammation       Date:  2017-09-02       Impact factor: 8.322

3.  Elevated microRNA-129-5p level ameliorates neuroinflammation and blood-spinal cord barrier damage after ischemia-reperfusion by inhibiting HMGB1 and the TLR3-cytokine pathway.

Authors:  Xiao-Qian Li; Feng-Shou Chen; Wen-Fei Tan; Bo Fang; Zai-Li Zhang; Hong Ma
Journal:  J Neuroinflammation       Date:  2017-10-23       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.